Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: Perspectives from a maxillofacial surgeon

Clinical Microbiology and Infection

Volumn 15, Issue SUPPL. 5, 2009, Pages 98-102

  Rapidis, A D ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Maxillectomy; Mucormycosis; Orbital exenteration; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; DEFEROXAMINE; ECHINOCANDIN; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; POLYENE ANTIBIOTIC AGENT; POSACONAZOLE; VORICONAZOLE;

BURN; CAVERNOUS SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; EYELID EDEMA; FACE PAIN; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; INFECTION RISK; IRON OVERLOAD; MAXILLOFACIAL SURGERY; MORTALITY; MOUTH ULCER; MUCORMYCOSIS; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT INFLAMMATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PTOSIS; RECOMMENDED DRUG DOSE; REVIEW; SOLID TUMOR; SURGICAL APPROACH; TISSUE NECROSIS;

FUNGI;

ANIMALS; DEBRIDEMENT; EYE DISEASES; HUMANS; MAXILLARY SINUS; MUCORMYCOSIS; ORBIT; PARANASAL SINUS DISEASES;

EID: 70349977636     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02989.x     Document Type: Review

References (37)

1. Ameen M, Arenas R, Martinez-Luna E, Reyes M, Zacarias R. The emergence of mucormycosis as an important opportunistic fungal infection: Five cases presenting to a tertiary referral center for mycology. Int J Dermatol 2007, 46:380-384.
2. Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia 2006, 162:1-15.
3. Paultauf A. Mycosis mucorina. Arch Pathol Anat 1885, 102:543.
4. Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 2005, 18:556-569.
5. Pagano L, Ricci P, Tonso A. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases. Gimema infection program (gruppo italiano malattie ematologiche maligne dell'adulto). Br J Haematol 1997, 99:331-336.
6. Nosari A, Oreste P, Montillo M. Mucormycosis in hematologic malignancies: An emerging fungal infection. Haematologica 2000, 85:1068-1071.
7. Islam MN, Cohen DM, Celestina LJ, Ojha J, Claudio R, Bhattacharyya IB. Rhinocerebral zygomycosis: An increasingly frequent challenge: Update and favorable outcomes in two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:e28-34.
8. Garcia-Covarrubias L, Bartlett R, Barratt DM, Wassermann RJ. Rhino-orbitocerebral mucormycosis attributable to apophysomyces elegans in an immunocompetent individual: Case report and review of the literature. J Trauma 2001, 50:353-357.
9. Hosseini SM, Borghei P. Rhinocerebral mucormycosis: Pathways of spread. Eur Arch Otorhinolaryngol 2005, 262:932-938.
10. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: A significant consequence of evolving antifungal prophylaxis and immunosuppression practices?. Clin Microbiol Infect 2009, 15.
11. Rutar T, Cockerham KP. Periorbital zygomycosis (mucormycosis) treated with posaconazole. Am J Ophthalmol 2006, 142:187-188.
12. Orguc S, Yuceturk AV, Demir MA, Goktan C. Rhinocerebral mucormycosis: Perineural spread via the trigeminal nerve. J Clin Neurosci 2005, 12:484-486.
13. Pagano L, Offidani M, Fianchi L. Mucormycosis in hematologic patients. Haematologica 2004, 89:207-214.
14. Petrikkos G, Skiada A, Sambatakou H. Mucormycosis: Ten-year experience at a tertiary-care center in greece. Eur J Clin Microbiol Infect Dis 2003, 22:753-756.
15. Uckay I, Chalandon Y, Sartoretti P. Invasive zygomycosis in transplant recipients. Clin Transplant 2007, 21:577-582.
16. O'Neill BM, Alessi AS, George EB, Piro J. Disseminated rhinocerebral mucormycosis: A case report and review of the literature. J Oral Maxillofac Surg 2006, 64:326-333.
17. Cheema SA, Amin F. Five cases of rhinocerebral mucormycosis. Br J Oral Maxillofac Surg 2007, 45:161-162.
18. Tugsel Z, Sezer B, Akalin T. Facial swelling and palatal ulceration in a diabetic patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98:630-636.
19. Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z. Rhino-orbitocerebral mucormycosis caused by apophysomyces elegans. J Clin Microbiol 2006, 44:892-898.
20. Franquet T, Gimenez A, Hidalgo A. Imaging of opportunistic fungal infections in immunocompromised patient. Eur J Radiol 2004, 51:130-138.
21. Mnif N, Hmaied E, Oueslati S. [imaging of rhinocerebral mucormycosis]. J Radiol 2005, 86:1017-1020.
22. Ghadiali MT, Deckard NA, Farooq U, Astor F, Robinson P, Casiano RR. Frozen-section biopsy analysis for acute invasive fungal rhinosinusitis. Otolaryngol Head Neck Surg 2007, 136:714-719.
23. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): Emerging clinical importance and new treatments. Curr Opin Infect Dis 2004, 17:517-525.
24. Bengel D, Susa M, Schreiber H, Ludolph AC, Tumani H. Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rrna gene sequence. Eur J Neurol 2007, 14:1067-1070.
25. Spellberg B, Fu Y, Edwards JE, Ibrahim AS. Combination therapy with amphotericin b lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005, 49:830-832.
26. Roden MM, Zaoutis TE, Buchanan WL. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005, 41:634-653.
27. Sims CR, Ostrosky-Zeichner L. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res 2007, 38:90-93.
28. Richardson M. Ambisome: Adds to the body of knowledge and familiarity of use. Acta Biomed 2006, 77(Suppl 4):3-11.
29. Schutz P, Behbehani JH, Khan ZU. Fatal rhino-orbito-cerebral zygomycosis caused by apophysomyces elegans in a healthy patient. J Oral Maxillofac Surg 2006, 64:1795-1802.
30. Barchiesi F, Spreghini E, Santinelli A. Posaconazole prophylaxis in experimental systemic zygomycosis. Antimicrob Agents Chemother 2007, 51:73-77.
31. Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin b. Haematologica 2005, 90:ECR39.
32. Nivoix Y, Zamfir A, Lutun P. Combination of caspofungin and an azole or an amphotericin b formulation in invasive fungal infections. J Infect. 2006, 52:67-74.
33. Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology 2000, 107:555-558.
34. Tidwell J, Higuera S, Hollier LH. LH, Facial reconstruction after mucormycosis in an immunocompetent host. Am J Otolaryngol 2005, 26:333-336.
35. Talmi YP, Goldschmied-Reouven A, Bakon M. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002, 127:22-31.
36. Pelton RW, Peterson EA, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: The use of multiple treatment modalities. Ophthal Plast Reconstr Surg 2001, 17:62-66.
37. Lari AR, Kanjoor JR, Vulvoda M, Katchy KC, Khan ZU. Orbital reconstruction following sino-nasal mucormycosis. Br J Plast Surg 2002, 55:72-75.